Sunday, 27 February 2011

Challenging the prevailing thought style


Frederick Grinnell


Nobel Laureate Albert Szent-Györgyi’s prescription for discovery was seeing what everybody else has seen and thinking what nobody else has thought. René Magritte’s 1936 oil painting Perspicacity shows a seated artist staring at a solitary egg on a draped table. On his canvas, he paints a bird in full flight. As expressed in Szent-Györgyi’s prescription and Magritte’s painting, discovery frequently requires unconventional thinking. The more novel a discovery claim, the greater its potential to refashion the thought style and affect subsequent research in the field. At the same time, novelty also challenges intersubjectivity and can come into conflict with the prevailing thought style. As a result, highly novel discovery claims sometimes are received with considerable skepticism by the research community.

I learned firsthand the difficulty of challenging the prevailing thought style when I was a postdoctoral fellow with Paul Srere. Srere was engaged in a dispute with many in the research community concerning how best to understand enzyme regulation. His focus was on the enzymes of the citric acid cycle. Many of these enzymes, he emphasized, were present in cells at much higher concentrations compared to those typically studied by biochemists. “But a cell is not a test tube!” Srere argued that understanding enzyme regulation required analysis of enzymes in the context of their supramolecular organization within cells.

Frustrated by the resistance of conventional thinking in the research community to his new ideas, Srere would begin his seminars by describing the I Ching. The I Ching is a Chinese philosophical system attributed to the Emperor Fu Hsi (circa 2800 B.C.E.) that is used to understand the past and predict the future. Paul explained to his audience (mockingly) that he was skeptical about the 5,000-year-old method until he examined the trigram symbols arranged in a circle. He was amazed to learn that Fu Hsi had predicted the citric acid cycle well before the cycle was discovered by Sir Hans Krebs. Then Srere would show the front cover of the Beatles 1969 album Abbey Road. He would point out some of the clues on the cover indicating that Paul McCartney had died, a popular conspiracy theory at the time. Srere told his listeners that he was fascinated “by the evidence, logic and inevitability of the conclusion that McCartney died.…It was a compelling story. The only flaw was that he was alive.” And then Srere reached his timeless conclusion: “Given a large mass of data, we can by judicious selection construct perfectly plausible unassailable theories—all of which, some of which, or none of which may be right”.

While the skepticism of conventional thinking can delay acceptance of new ideas, if the ideas are correct, then the research community eventually catches up. One sign of the research community catching up with Paul Srere was the establishment in 1987 of an ongoing research conference titled Enzyme Organization and Cell Function (later renamed Macromolecular Organization and Cell Function). In recognition of his contributions to the field, Srere’s fellow biochemists established the “Paul Srere Memorial Lecture” beginning with the 2004 conference.

The history of Nobel Prizes includes many examples of novel discoveries that were either ignored or disputed for years, for example, tumor viruses (Nobel Prize in 1966), chemiosmotic theory (Nobel Prize in 1978), transposable genetic elements (Nobel Prize in 1983), and catalytic ribonucleic acid (Nobel Prize in 1989). The presentation speech for Krebs when he won the 1953 Nobel Prize for the discovery of the citric acid cycle reminded the audience that “in the beginning Krebs was quite alone with his idea, and when he first presented it, it was criticized by many”. The presentation speech for Stanley Prusiner when he won the 1997 Nobel Prize for the discovery of prions contained similar remarks: The hypothesis that prions are able to replicate without a genome and to cause disease violated all conventional conceptions and during the 1980s was severely criticized. For more than 10 years, Stanley Prusiner fought an uneven battle against overwhelming opposition.

In the end, accommodation of the thought style to novelty frequently follows the path described by William James: “First, you know, a new theory is attacked as absurd; then it is admitted to be true, but obvious and insignificant; finally, it is seen to be so important that its adversaries claim that they themselves discovered it”.

Frederick Grinnell - Credibility: Validating Discovery Claims

Read more

Thursday, 24 February 2011

When catastrophe strikes a cancer cell


Jose M. C. Tubio & Xavier Estivill

How do the mutations that lead to cancer come about? The traditional view is that a gradual process involving continual acquisition of heritable genetic changes by cells causes cancer. There is, however, an alternative view that single catastrophic events can lead to multiple mutations. In a paper published in Cell, Stephens et al. provide evidence for the concept of catastrophism in cancer.

The authors coin the term chromothripsis (from ‘chromo’, for chromosome; and ‘thripsis’, for breaking into small pieces) to designate this phenomenon.

Stephens and colleagues combined next-generation sequencing and single nucleotide polymorphism (SNP) array data to analyse the patterns of somatic (non-germline) genomic rearrangements in tumours. Intriguingly, they found that in some cases the changes consist of tens to hundreds of rearrangements, confined to one or a few chromosomes.

Rearrangements are common in cancer, so how can the authors tell whether such mutations were caused by a single event? They argue that the final configuration of the rearrangements they observed could be explained only by a single catastrophic episode, rather than by a series of independent events. Rearrangements due to chromothripsis are usually restricted to a few chromosomes, within which breakpoints show a non-random distribution.

The potential implications of chromothripsis as a cause and/or mediator of cancer are evident. As Stephens et al. point out, the generation of so many rearrangements in a single genomic crisis makes it likely that more than one cancer-causing lesion would occur.

Read more in Nature

Friday, 11 February 2011

Common Disease: Are Causative Alleles Common or Rare?

Robert Shields from PLoS Biology

It has been said that a week is a long time in politics. But in human disease gene mapping, 10 years can seem a very short time indeed. It once seemed so simple: find a family with a number of affected individuals and narrow down regions of the genome shared by affected individuals but not their unaffected siblings. This process (family linkage analysis) was lengthy but had notable success with some diseases, including hereditary breast cancers caused by the BRCA1 and BRCA2 genes. Yet, many diseases known to have a genetic component (because they tend to run in families or siblings show a high concordance) do not follow a simple Mendelian pattern of inheritance and cannot be dissected in this way. Instead, researchers tried an “association” approach, starting with a large number of unrelated individuals, to find gene variants, or alleles, that are more common in affected than in unaffected controls. For such a strategy to work, the diseases must be influenced by variants that are quite common in the populations.

Some readers might recall the heated debates about the common disease, common variant (CD-CV) hypothesis. Using arguments based on population genetics (such as the rate of creation and purging of deleterious alleles, the genetic bottleneck in the human population and subsequent population expansion), the CD-CV hypothesis proposed that in common diseases with a genetic component, some predisposing alleles are relatively common and a combination of alleles or environmental effects was required before disease occurred, much like being dealt a bad hand from a common deck of cards. Under this hypothesis, disease-associated alleles might be found by using common gene variants, such as single nucleotide polymorphisms (SNPs), as a guide and comparing affected individuals with controls. Others cast doubt on this idea and suggested that common diseases are unlikely to be caused by common alleles and more likely to be caused by rarer ones; they too deployed arguments based on population genetics and suggested that association studies using common genetic variants might not be successful. As with all scientific debates, there seemed only one way out: collect the data and see. Well, 10 years and several millions of dollars later we have a lot of data, but are we any the wiser? Do we understand the allelic spectrum of disease any better than we did 10 years ago?

There have now been over 700 genome-wide association studies (GWAS) published linking many variants to over a hundred diseases. Many of these results are robust in that they can be replicated in several populations, leaving little doubt that common variants can contribute to common diseases. The problem is that the effect of these variants on disease is often rather modest, so that people with the disease-predisposing alleles are only slightly more likely to get the disease than those without. Larger and larger studies reveal more disease genes, usually with smaller and smaller effect on overall disease risk. The “missing heritability” problem then arises because, even in aggregate, these loci typically fall somewhat short of explaining the entire genetic component of disease risk. So where are the genes accounting for major predisposition to disease? One possible explanation is that GWAS do not directly reveal the disease-causative DNA variant, but rather a common DNA variant (usually an SNP) that is close enough to be genetically linked to it (almost always inherited together) and common enough to be on the genotyping microarrays. This has spurred more effort (and more expense) to find rarer and rarer SNPs by sequencing more genomes and make even larger arrays in the hope that the new SNPs may be in even closer linkage with the causative allele. Alternatively, it's possible that the disease-predisposing variants are not SNPs at all, but other changes in the genome, such as a duplicated or deleted gene or region—a so-called copy number variant (CNV)—or a result of epigenetic marks in the chromatin; neither of these would show up using the current generation of microarrays that look just at SNPs.

A paper published recently in PLoS Biology from the lab of David Goldstein put the cat amongst the CD-CV pigeons by suggesting that rather than common diseases being caused by common alleles, maybe rare alleles each with a large effect on disease might be creating “synthetic associations” in the GWAS signal by occurring, by chance, more often with one common allele than another. The paper used statistical reasoning to suggest that such synthetic associations are possible—but are they likely? Given how much time and money has been invested in surveying SNPs and attempting to match them up to diseases, the relative importance of such synthetic associations would have important implications on the direction of future research. The paper got a lot of publicity, even making the New York Times.

Now, some might say that no one likes the implication that they have been barking up the wrong scientific tree, still less perhaps that such a critique garnered a lot of publicity. But the issue is best settled by discussion—and data—which is why in this issue of PLoS Biology we publish two critiques of the original article together with a response from the original authors. The critiques argue that although rare variants could in theory create synthetic associations, this is not a likely explanation for the missing heritability. Perhaps with further advances in ever cheaper sequencing technologies and the ability to sequence whole genomes from affected individuals we will, before the next 10 years are up, finally have a better understanding of the missing pieces of the genetic causes of common disease.

Thursday, 10 February 2011

Protein Bias

From The Scientist:

New data show that protein research is stuck on a small set of molecules that was hot in the 1990s

At the dawn of the 21st century, scientists completed the first draft of the human genome and reported that human cells encode more than 20,000 proteins. But most of the protein research performed since has focused on about 2,000 proteins (mostly enzymes) that were already known and whose functions were well studied, according to an analysis published this week in Nature.

Why do you think researchers are less likely to study previously unexplored systems? The first reason is that scientists are sometimes just like dogs with a bone: They just love their problems. And they love going deeper and deeper, and it's the richness and the complexity of their problem that drives them.

The other thing is that you can get funding for proteins for which there's a preexisting community. The third thing is that when you rationalize your grant, we get rewarded for the elegance for which we weave a tale. You need to have context. When you go to publish a paper, if you work on an unknown protein, you're less likely to capture the imagination of the peer reviewers and they'll probably ask for a lot more work. To study an unknown protein, it takes longer, and that's what nobody has in this modern world -- time.

And then the last thing is research tools. There is no molecular biologist now who would not prefer to use a genome wide knockdown set of RNAis, for example, as opposed to the single RNAi. That's a better experiment, but no such tools exist for proteins. If you have a new protein, you have to make a knockout cell, you have to make an antibody, an inhibitor or mutant. It's a lot of work to create the infrastructure to even do the experiment.

Monday, 7 February 2011

Evolution at Two Levels: On Genes and Form

In their classic paper “Evolution at Two Levels in Humans and Chimpanzees", published exactly 30 years ago, Mary-Claire King and Allan Wilson described the great similarity between many proteins of chimpanzees and humans. They concluded that the small degree of molecular divergence observed could not account for the anatomical or behavioral differences between chimps and humans. Rather, they proposed that evolutionary changes in anatomy and way of life are more often based on changes in the mechanisms controlling the expression of genes than on sequence changes in proteins.

This article was a milestone in three respects. First, because it was the first comparison of a large set of proteins between closely related species, it may be considered one of the first contributions to “comparative genomics” (although no such discipline existed for another two decades). Second, because it extrapolated from molecular data to make inferences about the evolution of form, it may also be considered a pioneering study in evolutionary developmental biology. And third, its focus on the question of human evolution and human capabilities, relative to our losest living relative, marked the beginning of the quest to understand the genetic basis of the origins of human traits.

(...)

From the outset of this review, I make the sharp distinction between the evolution of anatomy and the evolution of physiology. Changing the size, shape, number, or color patterns of physical traits is fundamentally different from changing the chemistry of physiological processes. There is ample evidence from studies of the evolution of proteins directly involved in animal vision, respiration, digestive metabolism, and host defense that the evolution of coding sequences plays a key role in some (but not all) important physiological differences between species. In contrast, the relative contribution of coding or regulatory sequence evolution to the evolution of anatomy stands as the more open question.

Sean B. Carroll - Evolution at Two Levels: On Genes and Form

Heterotopy

Changes in the spatial regulation of toolkit genes and the genes they regulate are associated with morphological divergence.

A vast body of data has accumulated that has linked differences in where toolkit genes are expressed, or where the genes they regulate are expressed, with morphological differences between animals at various taxonomic levels. Most studies have analyzed situations in which the spatial location of a developmental process (for example, the making of a limb, the formation of a pigmentation pattern, the development of epithelial appendages, etc.) has been altered. The classical term for such spatial changes in development is heterotopy (changes in the timing of a process are known as heterochrony). The close correspondence between heterotopic shifts in gene expression, development, and morphology, combined with the known roles of these genes in model taxa, have provided compelling evidence that changes in morphology generally result from changes in the spatiotemporal regulation of gene expression during development.

Explanations for the evolution of anatomy have thus focused on the genetic and molecular mechanisms underlying the evolution of spatial gene regulation. And the keys to understanding spatial gene regulation are the architectures of gene-regulatory regions and transcriptional networks.


Sean B. Carroll. Cell 134, July 11, 2008.

Sunday, 6 February 2011

Functional Equivalence of Distant Orthologs and Paralogs

Many animal toolkit proteins, despite over 1 billion years of independent evolution in different lineages, often exhibit functionally equivalent activities in vivo when substituted for one another. These observations indicate that the biochemical properties of these proteins and their interactions with receptors, cofactors, etc. have diverged little over vast expanses of time.

What makes these results so surprising and notable is that the function of any transcription factor or ligand is dependent upon interaction with other endogenous proteins—transcription factors, coactivators, corepressors, and parts of the transcriptional machinery in the case of transcription factors, cell surface receptors in the case of ligands. One might expect that genetic drift or the coadaptation of proteins within lineages would lead to functional incompatibilities among proteins from different taxa, especially those separated by over 1 billion years of independent evolution. Yet, many proteins are so conserved that they can interact and function together with other proteins from long-diverged taxa. These results have been more the rule than the exception for transcription factors. Numerous studies of eukaryotic transcription demonstrate that the basic transcriptional machinery, many coactivators, corepressors, chromatin-remodeling complexes, and the protein motifs through which transcription factors interact with them, are often very well conserved.

Sean B. Carroll. Cell 134, July 11, 2008.

Saturday, 5 February 2011

Evolved genetic guesses

Once it is recognized that not all mutations are random mistakes, the way one sees the relationship between physiological and developmental adaptation and evolutionary adaptation begins to change. We are used to thinking of them as very different: physiological and developmental changes involve instruction - what happens in cell or organisms is controlled by internal or external regulatory signals; evolutionary changes involve selection - some heritable variants are preferred to others. In the jargon of philosophers of biology, the physiological and developmental processes that underlie a phenotype are "proximate causes", while evolutionary processes - natural selection and whatever else has constructed the phenotype during evolutionary history - are "ultimate causes".

Yet, if the generation of some heritable variation is under physiological or developmental control, how distinct are the two types of causes? Seeing evolution purely in terms of selection acting on randomly generated variation is wrong, because it involves instructive processes too. As we see it, the dichotomy between physiology/development and evolution, and between proximate and ultimate causes, it is not as absolute as we have been led to believe. They grade into one another. At one extreme there are purely selective processes, acting on chance variation, while at the other there are purely instructive processes,which are totally physiological or developmental and do not involve any selection. Between these extremes we find the majority of processes in the real world, which are to varying degrees both instructive and selective. Some developmental changes, such as those occurring during the development of the immune system, also involve selection, whereas some evolutionary changes, particularly in bacteria and plants, may have instructive components. In other words, Darwiniam evolution can include Lamarckian processes, because the heritable variation on which selection acts is not entirely blind to function; some of it is induced or "acquired" in response to the conditions of life.

From: Evolution in four dimensions by Eva jablonka and Marion J. Lamb

Wednesday, 2 February 2011

Time to have fun with a bad project

Gene swap key to evolution

Horizontal gene transfer accounts for the majority of prokaryotic protein evolution

Microbes evolve predominantly by acquiring genes from other microbes, new research suggests, challenging previous theories that gene duplication is the primary driver of protein evolution in prokaryotes.

The finding, published in PLoS Genetics, could change the way scientists study and model biological networks and protein evolution.

"Even at a meeting last summer, there were those that thought that bacteria genomes expanded mostly through duplications and others that argued that it was due to gene acquisition," wrote Howard Ochman, an evolutionary biologist at Yale University who was not involved in the research, in an Email to The Scientist. "Now we all have a paper to point to that does a very good job of answering this question," he said. "Their conclusions are really robust."

Prokaryotes, including bacteria and archaea, thrive in diverse conditions thanks to their ability to rapidly modify their repertoire of proteins. This is achieved in two ways: by receiving genes from other prokaryotes, called horizontal gene transfer -- the nefarious way that bacteria acquire antibiotic resistance -- or by gene duplication, in which an existing gene is copied, taking on a new or enhanced function as mutations accumulate.

Past analyses using few, distantly related genomes estimated that horizontal gene transfer contributes to, at best, 25 percent of the expansion of protein families -- that is, the addition of proteins with novel functions or structures. But the recent availability of numerous, closely related prokaryotic genomes tempted Todd Treangen and Eduardo Rocha at the Institut Pasteur in Paris to more accurately test which biological process is the main driver of prokaryote protein evolution. "The genomic data was finally there to do a more in depth study," said Treangen, now a postdoc at the University of Maryland.

The duo analyzed 110 genomes of varying size from 8 clades of prokaryotes, focusing in on 3,190 defined protein families. The results were unambiguous: 80 to 90 percent of protein families had expanded through horizontal gene transfer. In addition, the researchers found that the two processes have different evolutionary roles: transferred genes persist longer in populations while duplicated genes are transient but more highly expressed.

"Overall, the role of gene transfer in protein diversification has been underestimated," said Treangen. Still, he noted, they analyzed only a tiny fraction of the microbes that exist in the world, and further research should be done as more genomes become available.

It would be nice to study the same two processes in eukaryotes, said Patrick Keeling, a molecular evolutionary biologist at the University of British Columbia who was not involved in the research. Yet despite numerous documented cases of horizontal gene transfer in eukaryotes, including plants, it would be hard to test because of the lack of genomic data from enough closely related eukaryotes (which have significantly larger, less manageable genomes than prokaryotes).

Still, "it raises some really fascinating questions about whether [eukaryotes] evolve in the same way," said Keeling.

Treangen, T.J. et al., "Horizontal Transfer, Not Duplication, Drives the Expansion of Protein Families in Prokaryotes," PLoS Genetics, 7:e1101284, 2011.

The Scientist

Sunday, 12 December 2010

The Great DNA Data Deficit: Are Genes for Disease a Mirage?

Jonathan Latham and Allison Wilson

Just before his appointment as head of the US National Institutes of Health (NIH), Francis Collins, the most prominent medical geneticist of our time, had his own genome scanned for disease susceptibility genes. He had decided, so he said, that the technology of personalised genomics was finally mature enough to yield meaningful results. Indeed, the outcome of his scan inspired The Language of Life, his recent book which urges every individual to do the same and secure their place on the personalised genomics bandwagon.

So, what knowledge did Collins’s scan produce? His results can be summarised very briefly. For North American males the probability of developing type 2 diabetes is 23%. Collins’s own risk was estimated at 29% and he highlighted this as the outstanding finding. For all other common diseases, however, including stroke, cancer, heart disease, and dementia, Collins’s likelihood of contracting them was average.

Predicting disease probability to within a percentage point might seem like a major scientific achievement. From the perspective of a professional geneticist, however, there is an obvious problem with these results. The hoped-for outcome is to detect genes that cause personal risk to deviate from the average. Otherwise, a genetic scan or even a whole genome sequence is showing nothing that wasn’t already known. The real story, therefore, of Collins’s personal genome scan is not its success, but rather its failure to reveal meaningful information about his long-term medical prospects. Moreover, Collins’s genome is unlikely to be an aberration. Contrary to expectations, the latest genetic research indicates that almost everyone’s genome will be similarly unrevealing.

We must assume that, as a geneticist as well as head of NIH, Francis Collins is more aware of this than anyone, but if so, he wrote The Language of Life not out of raw enthusiasm but because the genetics revolution (and not just personalised genomics) is in big trouble. He knows it is going to need all the boosters it can get.

What has changed scientifically in the last three years is the accumulating inability of a new whole-genome scanning technique (called Genome-Wide Association studies; GWAs) to find important genes for disease in human populations. In study after study, applying GWAs to every common (non-infectious) physical disease and mental disorder, the results have been remarkably consistent: only genes with very minor effects have been uncovered. In other words, the genetic variation confidently expected by medical geneticists to explain common diseases, cannot be found.

Read more

Monday, 6 December 2010

Surprisingly sloppy yeast genes


Contrary to popular belief, the gene expression of "housekeeping" proteins in yeast is not synchronized or even coordinated.

Instead, these essential genes -- which work together to build important cell complexes like ribosomes and proteasomes -- are turned on and off randomly, researchers report in today's online edition of Nature Structural and Molecular Biology.

"We all have our biases about how things work," said senior author Robert Singer of the Albert Einstein College of Medicine in New York. "Sometimes, we're just wrong."

The surprising finding may change the way scientists understand and assess some gene transcription networks.

"It's fantastic work," said Mads Kaern, Canada Research Chair in systems biology at the University of Ottawa, who was not involved in the research. "This challenges the idea that elaborate networks have evolved to regulate this class of genes. That is profound."

Multi-protein complexes -- like ribosomes, made up of 80 different proteins -- perform essential functions in cells. Scientists have long assumed the expression of the genes required to assemble such complexes is coordinated because often the resulting proteins have similar abundances in cells. Additionally, it made logical sense that widely varying levels of subunits would result in malformed complexes or a build-up of toxic levels of unused proteins.

But in 2008, Singer and colleagues studying the expression of genes in yeast noticed that many constitutive genes -- those transcribed throughout the cell cycle rather than on an as-needed basis -- had irregular, random expression patterns. The unexpected finding led them to predict that the expression of genes needed for multi-protein complexes might not be synchronized, either.

When the team measured the expression of several groups of genes -- those encoding subunits of a proteasome, a transcription factor, and RNA polymerase II -- they found that the mRNAs of each group's subunits were no more correlated than the mRNAs of genes that had no functional relationship to each other. Even two alleles of the same gene with identical promoters were not expressed equally.

"The genes are essentially clueless," said Singer. "They don't know what they're making or the actual destiny of protein. They're just there, cranking out proteins." In contrast, induced genes -- those triggered by stimuli, such as a nearby toxin or nutrient-rich media -- demonstrated highly coordinated expression.

Consequently, the researchers assume that the coordination of protein abundances for complexes happens after transcription. Because many proteins have longer half-lives than mRNA, for example, random fluctuations in mRNA levels may be inconsequential because proteins stick around for significantly longer. Or perhaps chaperone molecules impose checkpoints, stabilizing ribosomes or proteasomes to prevent dissociation until the next subunit arrives. Or both.

"We have this bias about cells being efficient, but the more we learn about them, the more inefficient we find out they are," said Singer. "But maybe that's the way biological systems have to work. If they had too many controls, there's a lot more opportunity for things to go wrong."

The un-coordinated expression of constitutive genes may have an important evolutionary function, suggested Kaern. "They may make cells more robust, less sensitive to mutations in upstream regulators," he said. If constitutive genes shared one upstream activator to turn them all on simultaneously, a single mutation in that activator could have catastrophic consequences for the cell, he speculated.

Overall, the research has important implications for systems biology and researchers studying gene networks of constitutive genes. "This opens up a conceptual door that was previously ignored," said Kaern, who suspects something similar may occur in mice and human cells. "But I think a lot of yeast biologists will not be surprised [this happens in yeast] because they know how sloppy yeast is," he added. "It has a tendency to survive whatever you throw at it."

Source: The Scientist

Thursday, 25 November 2010

Cancer’s conversions

A developmental transition may be a useful model for tumor progression.

Until recently, the universally accepted dogma in cancer research stated that replicating cells accumulate several rounds of mutations before becoming cancerous. According to that dogma, the mutations that result in metastatic spread throughout the body occur late in tumor progression. This idea has recently been challenged by the identification of cancer stem cells (CSCs), which provide a new explanation for both the initiation and propagation of tumorigenesis. Rather than following a linear process that starts with unchecked replication and ends with the loss of adhesion molecules that drives metastasis, CSCs can self-renew, proliferate, differentiate, and even revert back to a stem cell state, producing metastatic cells at unexpected stages of the disease.

With a new understanding that cancer progression does not necessarily follow a particular order, researchers have been looking for models to help explain how and when cancers become aggressive. While the idea of CSCs helps explain some observations that do not fit within the accepted dogma, researchers have proposed another idea based on a normal process in embryonic development called the epithelial-to-mesenchymal transition (EMT). Embryonic development requires epithelial cells to change gene expression patterns, lose their adhesion molecules, and become motile, mesenchymal-like cells that invade the extracellular matrix and later differentiate to form the interior tissues of the body such as skeletal muscles and the heart. A similar process, which includes the loss of adhesion molecules and the activation of common genes by Wnt/β-catenin and other signaling pathways, is also a prerequisite for malignant tumor development, particularly the metastatic process. Studying the basic biology of EMT, therefore, could shed light on the processes that cancer cells undergo as they develop.

Read more

Saturday, 20 November 2010

Induced global mutations

Imagine that some organisms find themselves in an environment in which they can no longer survive or reproduce. Their only hope of salvation is that a lucky mutation will crop up and enable them to deal with their adverse circumstances. If mutation rates are low, which they usually are, the chances that any will survive are slim. But if they have mechanisms that kick in in stressful conditions and increase the rate of mutation throughout the genome, things might be better.Many individuals will perish quickly (they get mutations that make matters worst), but the chances that one or two will have a liberating mutation are enhanced.

(...)

The mutation rates in bacteria are enhanced when they encounter an environment that is so hostile that they completely stop growing and reproducing. In such conditions, a spate of new mutations is generated throughout the genome. Every little single mutation is random, in the sense that it is not function-specific, but the general genomic response - the increased mutation rate - may be adaptive.

(...)

Not everyone accepts that stress-induced mutation is an evolved adaptation, however. Some people argue that the spate of mutations that occur in adverse conditions is simply a by-product of stress-induced failure. When cells are stressed, especially when starved, one of the things that may happen is that they are no longer able to produce the proteins needed for DNA maintenance and repair. It may even be that starved cells are obliged to turn off their DNA-caretaker genes to save energy. If so, faults will occur and remain uncorrected. In other words, there will be a lot of mutations. In this case, the generation of mutations is just a pathological symptom of the problems cells are experiencing, not an evolved adaptive response to adverse conditions.

From: Eva Jablonka & Marion Lamb - Evolution in four dimensions

Wednesday, 17 November 2010

Molecular animations

Suggested by Glen Oomen (Medical Illustrator) & Serena Jennings (my colleague):



Sunday, 14 November 2010

Population thinking

Generalizations in biology are almost invariably of a probabilistic nature. As one wit has formulated it, there is only one universal law in biology: "All biological laws have exceptions". This probabilistic conceptualization contrasts strikingly with the view during the early period of the scientific revolution that causation in nature is regulated by laws that can be stated in mathematical terms. Actually, this idea occurred apparently first to Pythagoras. It has remained a dominant idea, particularly in the physical sciences, up to the present day. (...) With Plato, it gave rise to the essentialism. For him, the variable world of phenomena was nothing but the reflection of a limited number of fixed and unchanging forms, the essences. These essences are what is real and important in this world. Constancy and discontinuity are the points of special emphasis for the essentialists. Variation is attributed to the imperfect manifestation of the underlying essences.

(...)

Darwin, one of the first thinkers to reject the essentialism (at least in part), was not at all understood by the contemporary philosophers (all of whom were essentialists), and his concept of evolution through natural selection was therefore found unacceptable. Genuine change, according to essentialism, is possible only through the saltatation origin of new essences. Because evolution as explained by Darwin, is by necessity gradual, it is quite incompatible with essentialism.

Western thinking for more than two thousand years after Plato was dominated by essentialism. It was not until the nineteenth century that a new and different way of thinking about nature began to spread, so-called population thinking. What is population thinking and how does it differ from essentialism? Population thinkers stress the uniqueness of everything in the organic world. What is important for them is the individual, not the type. They emphasize that every individual in sexually reproducing species is uniquely different from all others, with much individuality even existing in uniparentally reproducing ones. There is no "typical" individual, and mean values are abstractions. Much of what in the past has been designated in biology as "classes" are populations consisting of unique individuals.

From Ernst Mayr - The Growth of Biological Thought

Tuesday, 2 November 2010

Strong immunity = low fertility

A study in wild sheep may help explain why natural selection has not eradicated weak or self-destructive immune systems

A fluctuating trade-off between reproduction and survival in a feral population of Soay sheep may resolve the age-old question of why natural selection has failed to eradicate genes for both infection-prone and self-assailing immune systems.

The potential answer, published in Science this week (29th October), comes from the nascent field of ecoimmunology, which examines how different levels of antibodies in the blood of wild animals can influence their ability to survive and produce young.

Specifically, the authors found that, among a population of isolated, wild sheep, individuals with higher levels of antibodies associated with autoimmunity in other species were more likely to survive harsh weather conditions, but also reproduced less. Consequently, the benefits of high immunity, such as quick and efficient riddance of infection, may come with a cost -- less energy for reproduction.

"This paper reveals that more [antibodies] might not always be better, and that to understand the evolution of immune systems, it will be critical to study them in free-living, outbred organisms," Lynn Martin, an ecoimmunologist at the University of South Florida, who was not affiliated with the study, said in an email to The Scientist.

Researchers have found that feral rodents can hold comparatively high concentrations of antibodies in their blood, but, mysteriously, autoimmunity diseases such as type 1 diabetes and lupus are only seen in humans and lab, domestic, and captive mammals, said Andrea Graham, an evolutionary biologist at Princeton University and first author on the study.

There was "this nagging question of whether autoimmunity was some weird freak of captivity," added Andrew Read, evolutionary biologist at Pennsylvania State University, who did not contribute to the study.

Using blood samples collected every August for 11 years from the Soay sheep population on Hirta, an island in the St. Kilda archipelago of Scotland, Graham and colleagues from the University of Edinburgh in Scotland measured the concentration of antinuclear antibodies (ANAs), or autoimmune antibodies that attack the contents of the cell's nucleus as if it were foreign material. They then compared these levels to other variables of fitness such as survival and reproduction.

Researchers found that adult females with higher levels of ANAs lived longer by surviving more bitterly cold, parasite-infested winters. However, these same females were less likely to have babies the following spring. The correlation was only present during particularly harsh winters, however, when sometimes nearly 50 percent of the population died, suggesting heterogeneity in immune response is produced by natural selection acting on an ever-changing environment.

Ewes with high levels of ANAs also produced young with higher chances of survival through the next winter than young born to mothers with weak immune systems, suggesting a genetic basis for the varied immune responses in the sheep population.

"Immune response is only one part of the fitness component," said Peter Hudson, a disease ecologist at Pennsylvania State University, who was not affiliated with the study. "When [an individual] is not being exposed to pathogens, then high immune response could be too costly."

According to the results, when parasite prevalence is low and food is abundant, individuals with low immune responses will have the highest fitness because they will have the energy to produce the most young in the shortest period of time. But when the threat of infection is high and the winters are brutally frigid, individuals with high immune responses will survive and live on to have more children, while others die off. Thus, these trade-offs exhibited by the Soay sheep can account for their heterogeneity in immune response.

Read and Martin agreed that the next step is to experimentally manipulate antibody response in large populations to discover whether a causal, rather than correlational, relationship is present in this survival-reproduction trade-off.

The field of ecoimmunology "has been a controversial field because it's really hard to decide what to measure without a history [of the population]," noted Read.

This study demonstrates its potential benefits, however, Graham argued. "I firmly believe that we wouldn't have been able to find out such cool things about the immune system without this long study on the Soay sheep," she said. "Now that we understand all the nuts and bolts of the immune system [from traditional immunology], we can go on to try to understand it in the real world, because that's what really matters."

A. Graham et al., "Fitness Correlates of Heritable Variation in Antibody Responsiveness in a Wild Mammal," Science, 330:662-65, 2010.

Source: The Scientist

Top 7 genetics papers

A snapshot of the highest-ranked articles in genetics and related areas in the past 30 days

1. Mapping transcriptomes
While mapping every transcriptional start site and operon of Helicobacter pylori at single-nucleotide resolution, the authors identify novel small RNAs, reveal the widespread nature of antisense transcription, and unveil a new technique to investigate the genomic complexities of other important pathogens, such as Salmonella and Mycobacterium tuberculosis.

2. Epigenetics in mind
The body's tendency to silence the expression of one parental allele in favor of the other -- a phenomenon known as genomic imprinting -- is much more widespread in the brain than scientists have believed, according to a new genome-wide study in mice. Surprisingly, more than 1300 genes expressed in the mouse brain appear to exhibit "parent-of-origin" epigenetic effects.

3. Translation goes local
Protein synthesis is a complicated game, but for the first time researchers have shown direct interaction between a transmembrane receptor, called DCC, and the translational machinery in rodent neurons, a step that likely facilitates localized protein production.

4. No RNA "dark matter"?
Most of the DNA that's transcribed into RNA in fact codes for proteins, a finding that disputes previous studies that suggested that the majority of mammalian transcripts are non-coding "dark matter."

5. Super E. Coli
The mother cell of E. coli maintains a constant growth rate throughout its replicative life (hundreds of cell divisions), despite accumulating damage and an increased probability of death, suggesting that growth and aging are decoupled, unlike all other studied aging models.

6. How autophagosomes form
Under conditions of starvation, autophagosomes form to resupply the cell by bringing nutrients from the cytosol or other organelles to the lysosomes, ensuring the cell's survival. New findings reveal an essential ingredient to this mysterious process: the outer membrane of mitochondria.

7. New tumor targets?
A scan of 1800 megabases of DNA from 441 tumors reveals more than 2500 somatic mutations, providing the mutation "spectra" for cancers, including protein kinases and G-protein-coupled receptors, some of which may serve as druggable targets.

Source: The scientist

What is systems biology?

For the fun of it, here are a few examples of definitions:

To understand complex biological systems requires the integration of experimental and computational research -- in other words a systems biology approach. (Kitano, 2002)

Systems biology studies biological systems by systematically perturbing them (biologically, genetically, or chemically); monitoring the gene, protein, and informational pathway responses; integrating these data; and ultimately, formulating mathematical models that describe the structure of the system and its response to individual perturbations. (Ideker et al, 2001)

[...]the objective of systems biology [can be] defined as the understanding of network behavior, and in particular their dynamic aspects, which requires the utilization of methematical modeling tightly linked to experiment. (Cassman, 2005)

By discovering how function arises in dynamic interactions, systems biology addresses the missing links between molecules and physiology. Top-down systems biology identifies molecular interaction networks on the basis of correlated molecular behavior observed in genome-wide "omics" studies. Bottom-up systems biology examines the mechanisms through which functional properties arise in the interactions of known components. (Bruggeman and Westerhoff, 2007)

Why is it so difficult to come up with a concise definition of systems biology? One of the reasons might be that every definition has to respect a delicate balance between "the yin and the yang" of the discipline: the integration of experimental and computational approaches; the balance between genome-wide systematical approaches and smaller-scale quantitative studies; top-down versus bottom-up strategies to solve systems architecture and functional properties. But despite the diversity in opinions and views, there might be two main aspects that are conserved across these definitions: a) a system-level approach attempts to consider all the components of a system; b) the properties and interactions of the components are linked with functions performed by the intact system via a computational model. This may in fact reveal another source of difficulty when trying to define systems biology, which is to find a general and objective definition of "biological function" (or Lander's "goal of the system", see our brief post Teleology and Systems Biology). Feel free to comment and suggest on this...

From http://blog-msb.embo.org/blog/2007/07/
Posted originally by Thomas on July 23, 2007

Thursday, 28 October 2010

Fine-grained exploration

Many, if not all, complex systems in biology have a fine-grained architecture, in that they consist of large numbers of relatively simple elements that work together in a highly parallel fashion.

Several possible advantages are conferred by this type of architecture, including robustness, efficiency, and evolvability. One additional major advantage is that a fine-grained parallel system is able to carry out what Douglas Hofstadter has called a "parallel terraced scan". This refers to a simultaneous exploration of many possibilities and pathways, in which the resources given to each exploration at a given time depend on the perceived success of that exploration at that time. The search is parallel in that many different possibilities are explored simultaneously, but is "terraced" in that not all possibilities are explored at the same speeds or to the same depth. Information is used as it is gained to continually reasses what is important to explore.

In cellular metabolism such fine-grained explorations are carried out by metabolic pathways, each focused on carrying out a particular task. A pathway can be speeded up or slowed down via feedback from its own results or from other pathways. The feedback itself is in the form of time-varying concentrations of molecules, so the relative speeds of different pathways can continually adapt to the moment-to-moment needs of the cell.

Melanie Mitchell - Complexity: a guided tour.